Last reviewed · How we verify
E3112
At a glance
| Generic name | E3112 |
|---|---|
| Sponsor | EA Pharma Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- E3112 CI brief — competitive landscape report
- E3112 updates RSS · CI watch RSS
- EA Pharma Co., Ltd. portfolio CI